Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Biological E. Limited
Location
T. Score
Peers
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
People
Network
Registered Details

BIOLOGICAL E. LIMITED

Active

Updated: 23 Oct 2024

Biological E. Limited operates as a biological products company that develops, manufactures, markets, and supplies preventive medicines, vaccines, and pharmaceutical products.

Biological E. Limited, is an unlisted public company incorporated on 10 December, 1953. It is classified as a public limited company and is located in Andhra Pradesh, Telangana. It's authorized share capital is INR 5.00 cr and the total paid-up capital is INR 4.95 cr.

Industry

Agriculture and Allied Activities

Products

and respiratory therapy products, gastrointestinal therapy, immunization vaccines; active pharmaceutical ingredients; and anti infective, as well as sera and other biological products., anticoagulants, analgesics and antipyretic, nutraceuticals

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Sales

-34.39%

₹ 2,401.1

EBITDA

-48.64%

₹ 603.8

Net Profit

-17.12%

₹ 749.3

Networth

25.14%

₹ 3,758.2

Borrowings

-6.86%

₹ 1,792.6

Assets

-6.94%

₹ 7,499.0

Gross Margin

6.92

83.9 %

Operating Margin

-6.97

25.1 %

Net Profit Margin

5.46

29.4 %

Return on Equity

-10.16

19.9 %

ROCE

-21.48

11.0 %

Debt to Equity

-0.16

0.5

Sales

Mar 2024

Net worth

Mar 2024

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

View subscriptions and buy credits

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
- Litigation and more
Due diligence report

₹ 2999
- Everything in financial report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

Locations

India (39)

State	Type	Address

Locations on Map

Tofler Score

Good

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

PAYABLES DETERIORATING
LOW CASH BALANCE
REVENUE BELOW AVERAGE

Low Risk

HIGH INVENTORY
ROCE DETERIORATING
REVENUE DECLINE

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Peers / Similar Companies

Pfizer Limited Maharashtra

Sanofi Healthcare India Private Limited Maharashtra

Msd Pharmaceuticals Private Limited Delhi

Indian Immunologicals Limited Telangana

Serum Institute Of India Private Limited Maharashtra

Peers

Pfizer Limited

Maharashtra

Sanofi Healthcare India Private Limited

Maharashtra

Msd Pharmaceuticals Private Limited

Delhi

Indian Immunologicals Limited

Telangana

Serum Institute Of India Private Limited

Maharashtra

Financial Highlights

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	921.2	1,274.9	2,475.8	3,659.4	2,401.1
Operating profit	36.2	225.4	652.8	1,175.6	603.8
Net profit	100.9	169.7	392.9	904.1	749.3
Gross margin	85.3	85.9	82.6	77.0	83.9
Operating margin	3.9	17.7	26.4	32.1	25.1
Net margin	9.4	12.0	15.2	24.0	29.4
Networth	1,565.9	1,729.6	2,120.0	3,003.2	3,758.2
Borrowings	866.6	654.3	1,781.9	1,924.5	1,792.6
Assets	2,851.6	3,480.0	7,395.5	8,058.1	7,499.0
Debt to equity	0.6	0.4	0.8	0.6	0.5
Current ratio	3.2	1.6	1.2	1.2	1.6
ROE	6.4	9.8	18.5	30.1	19.9
Days payable	392.0	322.0	210.0	309.0	586.0
WC days	324.0	145.0	95.0	70.0	222.0

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	5.0	5.0	5.0	5.0	5.0
Reserves	1,560.9	1,724.6	2,115.1	2,998.3	3,753.3
Borrowings +	866.6	654.3	1,781.9	1,924.5	1,792.6
Long term borrowings	797.3	654.3	660.3	706.1	604.8
Short term borrowings	69.3	-	1,121.6	1,218.4	1,187.8
Trade payables +	145.7	158.6	248.1	714.5	621.3
Days payable	392.0	322.0	210.0	309.0	586.0
Other liabilities +	419.1	1,096.2	3,493.5	3,130.4	1,948.2
Other non-current liabilities	109.8	276.7	675.6	431.0	648.4
Other current liabilities	163.5	660.8	2,569.8	1,984.8	678.4
Total liabilities	2,851.6	3,480.0	7,395.5	8,058.1	7,499.0
Fixed Assets +	1,309.6	1,598.2	2,229.7	2,523.0	2,600.6
Tangible assets	1,136.6	1,079.5	1,319.8	1,635.9	1,857.0
CWIP	169.0	513.4	793.9	771.2	594.8
Intangible assets	4.0	5.3	116.0	115.9	148.8
LT loans and advances	10.4	13.1	13.4	16.8	18.5
Other non-current assets	335.1	544.3	566.6	894.6	934.7
Current assets +	1,196.5	1,324.5	4,585.8	4,623.7	3,945.2
Inventories	646.8	797.6	3,186.9	2,969.8	2,895.2
Trade receivables	188.2	120.9	748.1	1,310.3	433.9
Cash and cash equivalents	35.4	98.3	40.7	34.3	36.8
ST loans and advances	18.7	52.4	21.2	23.5	-
Other current assets	307.3	255.3	588.9	285.9	579.4
Total assets	2,851.6	3,480.0	7,395.5	8,058.1	7,499.0

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	0.17	0.14	0.07	0.06	0.07
Reserves	54.74	49.56	28.6	37.21	50.05
Borrowings +	30.39	18.8	24.09	23.88	23.9
Long term borrowings	27.96	18.8	8.93	8.76	8.06
Short term borrowings	2.43	0.0	15.17	15.12	15.84
Trade payables	5.11	4.56	3.35	8.87	8.29
Other liabilities +	14.7	31.5	47.24	38.85	25.98
Other non-current liabilities	3.85	7.95	9.14	5.35	8.65
Other current liabilities	5.73	18.99	34.75	24.63	9.05
Total liabilities
Fixed Assets +	45.93	45.92	30.15	31.31	34.68
Tangible assets	39.86	31.02	17.85	20.3	24.76
CWIP	5.93	14.75	10.73	9.57	7.93
Intangible assets	0.14	0.15	1.57	1.44	1.98
LT loans and advances	0.36	0.38	0.18	0.21	0.25
Other non-current assets	11.75	15.64	7.66	11.1	12.46
Current assets +	41.96	38.06	62.01	57.38	52.61
Inventories	22.68	22.92	43.09	36.85	38.61
Trade receivables	6.6	3.47	10.12	16.26	5.79
Cash and cash equivalents	1.24	2.82	0.55	0.43	0.49
ST loans and advances	0.66	1.51	0.29	0.29	0.0
Other current assets	10.78	7.34	7.96	3.55	7.73
Total assets

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	-	-	5.0	5.0	5.0
Reserves	-	-	2,054.4	3,023.8	3,844.1
Borrowings +	-	-	660.3	1,924.5	1,792.5
Long term borrowings	-	-	660.3	706.1	604.8
Short term borrowings	-	-	-	1,218.4	1,187.7
Trade payables +	-	-	251.5	724.1	557.2
Days payable	286.0	335.0	204.0	318.0	507.0
Other liabilities +	-	-	4,630.5	3,152.8	1,952.9
Other non-current liabilities	-	-	671.4	423.4	643.7
Other current liabilities	-	-	3,707.6	2,005.3	752.0
Total liabilities	-	-	7,350.1	8,106.0	7,594.5
Fixed Assets +	-	-	2,384.4	2,577.4	2,682.7
Tangible assets	-	-	1,420.2	1,650.9	1,881.0
CWIP	-	-	823.4	771.2	636.1
Intangible assets	-	-	140.9	155.3	165.6
LT loans and advances	-	-	29.1	16.9	-
Other non-current assets	-	-	206.3	635.0	650.4
Current assets +	-	-	4,730.4	4,876.7	4,261.4
Inventories	-	-	3,205.5	2,994.2	2,939.5
Trade receivables	-	-	811.2	1,392.0	550.5
Cash and cash equivalents	-	-	81.9	117.8	102.5
ST loans and advances	-	-	19.9	24.2	20.7
Other current assets	-	-	612.0	348.5	648.1
Total assets	-	-	7,350.1	8,106.0	7,594.5

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	0.18	0.14	0.07	0.06	0.07
Reserves	54.52	49.49	27.95	37.3	50.62
Borrowings +	30.88	18.9	8.98	23.74	23.6
Long term borrowings	28.41	18.9	8.98	8.71	7.96
Short term borrowings	2.47	0.0	0.0	15.03	15.64
Trade payables	3.95	4.86	3.42	8.93	7.34
Other liabilities +	14.42	31.46	63.0	38.89	25.71
Other non-current liabilities	3.81	7.87	9.13	5.22	8.48
Other current liabilities	6.66	18.74	50.44	24.74	9.9
Total liabilities
Fixed Assets +	47.4	49.6	32.44	31.8	35.32
Tangible assets	40.92	32.65	19.32	20.37	24.77
CWIP	6.02	16.34	11.2	9.51	8.38
Intangible assets	0.45	0.61	1.92	1.92	2.18
LT loans and advances	0.91	0.4	0.4	0.21	0.0
Other non-current assets	5.29	8.21	2.81	7.83	8.56
Current assets +	46.4	41.8	64.36	60.16	56.11
Inventories	23.21	23.32	43.61	36.94	38.71
Trade receivables	5.06	4.34	11.04	17.17	7.25
Cash and cash equivalents	2.97	5.33	1.11	1.45	1.35
ST loans and advances	0.4	0.86	0.27	0.3	0.27
Other current assets	14.76	7.95	8.33	4.3	8.53
Total assets

Total assets

Profit & Loss

Standalone

Consolidated

₹

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales +	921.2	1,274.9	2,475.8	3,659.4	2,401.1
Sales growth %	-1.41	38.39	94.2	47.81	-34.39
Expenses +	972.4	1,173.0	1,986.1	2,787.8	2,143.0
Cost of goods	135.7	179.9	430.6	842.9	386.9
Employee cost	245.7	297.7	415.1	454.0	476.3
Other costs	503.6	571.8	977.2	1,186.9	934.1
Operating profit +	36.2	225.4	652.8	1,175.6	603.8
Operating margin %	3.9	17.7	26.4	32.1	25.1
Other income	155.2	143.2	112.0	110.5	144.2
Interest	32.2	42.2	65.3	178.5	189.7
Depreciation	55.2	81.4	97.9	125.5	155.9
Exceptional items	47.3	-	-	-314.1	508.3
Profit before tax	151.3	245.1	601.7	668.0	910.7
Tax	50.4	75.3	208.8	-236.1	161.4
Profit - disc. ops	-	-	-	-	-
Net profit	100.9	169.7	392.9	904.1	749.3
Net margin %	9.4	12.0	15.2	24.0	29.4

Precentage of total income	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	85.58	89.9	95.67	97.07	94.33
Expenses +	90.34	82.72	76.75	73.95	84.19
Cost of goods	12.61	12.69	16.64	22.36	15.2
Employee cost	22.83	20.99	16.04	12.04	18.71
Other costs	46.79	40.32	37.76	31.48	36.7
Operating profit	3.36	15.9	25.23	31.18	23.72
Other income	14.42	10.1	4.33	2.93	5.67
Interest	2.99	2.97	2.52	4.73	7.45
Depreciation	5.12	5.74	3.78	3.33	6.13
Exceptional items	4.39	0.0	0.0	-8.33	19.97
Profit before tax	14.05	17.28	23.25	17.72	35.78
Tax	4.68	5.31	8.07	-6.26	6.34
Profit - disc. ops	0.0	0.0	0.0	0.0	0.0
Net profit	9.37	11.97	15.18	23.98	29.44

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales +	-	-	2,539.1	3,743.8	2,557.0
Sales growth %	-2.46	43.92	18441834.59	47.45	-31.7
Expenses +	-	-	2,106.0	2,820.2	2,237.2
Cost of goods	-	-	450.3	831.9	401.2
Employee cost	-	-	466.1	473.8	497.5
Other costs	-	-	1,017.5	1,203.7	988.5
Operating profit +	-	-	605.1	1,234.4	669.8
Operating margin %	3.4	18.5	23.8	33.0	26.2
Other income	-	-	116.3	120.3	151.0
Interest	-	-	65.6	177.7	188.9
Depreciation	-	-	106.4	133.0	161.1
Exceptional items	-	-	-	-314.1	508.3
Profit before tax	-	-	549.4	729.8	979.1
Tax	-	-	212.3	-224.4	173.7
Profit - disc. ops	-	-	-	-	4.8
Net profit	-	-	337.2	954.3	810.2
Net margin %	5.2	12.0	12.7	24.7	29.9

Precentage of total income	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	85.51	90.48	95.62	96.89	94.42
Expenses +	91.43	82.58	79.31	72.98	82.61
Cost of goods	12.67	12.03	16.96	21.53	14.82
Employee cost	22.83	20.98	17.55	12.26	18.37
Other costs	47.14	40.7	38.32	31.15	36.5
Operating profit	2.87	16.76	22.79	31.95	24.73
Other income	14.49	9.52	4.38	3.11	5.58
Interest	3.66	3.18	2.47	4.6	6.97
Depreciation	5.13	5.68	4.01	3.44	5.95
Exceptional items	2.2	-0.05	0.0	-8.13	18.77
Profit before tax	10.77	17.37	20.69	18.89	36.16
Tax	5.37	5.37	7.99	-5.81	6.41
Profit - disc. ops	0.0	0.0	0.0	0.0	0.18
Net profit	5.16	11.99	12.7	24.7	29.92

Revenue from operations

Ratios

Standalone

Consolidated

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Solvency +
Total Debt/Equity	0.6	0.4	0.8	0.6	0.5
Net Debt/Equity	0.5	0.3	0.8	0.6	0.5
Total Debt/Assets	0.3	0.2	0.2	0.2	0.2
Total Assets/Equity	1.8	2.0	3.5	2.7	2.0
Liquidity +
Current Ratio	3.2	1.6	1.2	1.2	1.6
Quick Ratio	1.4	0.6	0.4	0.4	0.4
Interest Coverage	1.1	5.3	10.0	6.6	3.2
Performance
Gross Margin	85.3	85.9	82.6	77.0	83.9
Operating Margin	3.9	17.7	26.4	32.1	25.1
Net Margin	9.4	12.0	15.2	24.0	29.4
Return +
Return on Equity	6.4	9.8	18.5	30.1	19.9
Pre-tax ROCE	-0.9	6.8	19.3	32.5	11.0
Return on Assets	3.5	4.9	5.3	11.2	10.0
Pre-tax ROIC	-0.8	6.3	14.4	21.5	8.1
Efficiency +
Days Payable	392.0	322.0	210.0	309.0	586.0
Days Inventory	1,740.0	1,618.0	2,701.0	1,286.0	2,731.0
Days Receivable	75.0	35.0	110.0	131.0	66.0
Fixed Asset Turnover	0.7	0.8	1.1	1.4	0.9
Total Asset Turnover	0.3	0.4	0.3	0.5	0.3
Working Capital
Cash Conversion Cycle	1,423.0	1,331.0	2,601.0	1,108.0	2,211.0
Working Capital Days	324.0	145.0	95.0	70.0	222.0

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Solvency +
Total Debt/Equity	0.6	0.4	0.3	0.6	0.5
Net Debt/Equity	0.5	0.3	0.3	0.6	0.4
Total Debt/Assets	0.3	0.2	0.1	0.2	0.2
Total Assets/Equity	1.8	2.0	3.6	2.7	2.0
Liquidity +
Current Ratio	3.5	1.8	1.2	1.2	1.7
Quick Ratio	1.8	0.8	0.4	0.5	0.5
Interest Coverage	0.8	5.3	9.2	7.0	3.5
Performance
Gross Margin	85.2	86.7	82.3	77.8	84.3
Operating Margin	3.4	18.5	23.8	33.0	26.2
Net Margin	5.2	12.0	12.7	24.7	29.9
Return +
Return on Equity	3.8	10.6	16.4	31.5	21.1
Pre-tax ROCE	-1.1	7.2	15.8	31.4	11.4
Return on Assets	2.1	5.3	4.6	11.8	10.7
Pre-tax ROIC	-1.1	7.7	18.9	22.8	9.2
Efficiency +
Days Payable	286.0	335.0	204.0	318.0	507.0
Days Inventory	1,678.0	1,610.0	2,598.0	1,314.0	2,674.0
Days Receivable	54.0	40.0	117.0	136.0	79.0
Fixed Asset Turnover	0.7	0.8	1.1	1.4	0.9
Total Asset Turnover	0.3	0.4	0.3	0.5	0.3
Working Capital
Cash Conversion Cycle	1,446.0	1,315.0	2,511.0	1,132.0	2,246.0
Working Capital Days	357.0	167.0	111.0	91.0	252.0

Ratios

Current ratio

Debt/equity ratio

Charges on assets

Bank wise

Charges

State Bank of India

No. of Loans: 1

Total Amount : 813.3 cr

SBICap Trustee Company Limited

No. of Loans: 2

Total Amount : 657.0 cr

HDFC Bank Limited

No. of Loans: 2

Total Amount : 580.0 cr

Axis Bank Limited

No. of Loans: 3

Total Amount : 467.1 cr

BANK OF BARODA ,

No. of Loans: 1

Total Amount : 300.0 cr

UNIT TRUST OF INDIA

No. of Loans: 2

Total Amount : 2.1 cr

The Vysya Bank Limited

No. of Loans: 1

Total Amount : 0.1 cr

Uttar Pradesh Financial Corporation

No. of Loans: 1

Total Amount : 0.0 cr

UTTAR PRADESH FINANCIAL CORP.

No. of Loans: 1

Total Amount : 0.0 cr

Charge Holder	Amount	Date of creation/modification
State Bank of India	813.3 cr	25 Jul, 2024
SBICap Trustee Company Limited	432.0 cr	13 Mar, 2024
SBICap Trustee Company Limited	225.0 cr	13 Mar, 2024
Axis Bank Limited	2.1 cr	01 Dec, 2023
BANK OF BARODA ,	300.0 cr	17 Nov, 2022
HDFC Bank Limited	350.0 cr	31 May, 2022
Axis Bank Limited	100.0 cr	22 Mar, 2022
Axis Bank Limited	365.0 cr	22 Mar, 2022
HDFC Bank Limited	230.0 cr	09 Mar, 2022
UNIT TRUST OF INDIA	2.0 cr	15 Apr, 1993
The Vysya Bank Limited	0.1 cr	18 Jan, 1993
UNIT TRUST OF INDIA	0.1 cr	11 Jun, 1990
UTTAR PRADESH FINANCIAL CORP.	0.0 cr	24 Aug, 1973
Uttar Pradesh Financial Corporation	0.0 cr	11 Aug, 1971

Charges

State Bank of India

SBICap Trustee Company Limited

HDFC Bank Limited

Axis Bank Limited

Others

People

Designation	Name	DIN/PAN	Tenure
Director	Ippagunta Yasodhara Rama Krishna Rao	00481367	8 years
Director	Indira Smriti Rajupusapati	00482381	1 years
Director	Mantena Purnima	00965007	1 years
Managing Director	Mahima Datla Shareholder	00965039	12 years
CS	Mahipal Reddy Saddi	<HIDDEN>	10 years
Whole-time Director	Rudaraju Anand Kumar	07964480	7 years

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address
ORIENT CEMENT LIMITED	Active	20.5 Cr	1	Orissa
BIOTECH MEDICALS PRIVATE LIMITED	Active	1.0 Cr	3	Telangana
D.A.P. CONTAINERS PRIVATE LIMITED	Active	6.0 L	2	Telangana
V.R. INVESTMENTS AND FINANCE PRIVATE LIMITED	Strike Off	10.0 L	3	Maharashtra
V.R.CONSTRUCTION PVT LTD	Active	10.0 L	2	Telangana
V R PACKING COMPANY PRIVATE LIMITED	Active	5.0 L	2	Telangana
LACTO-COSMETICS (AP) PVT LTD	Active	5.0 L	3	Telangana
LACTO-COSMETICS (HYD) PVT LTD	Active	5.0 L	3	Telangana
TECHNOPHARMA PVT LTD	Active	5.0 L	3	Telangana
BIOTECH PHARMA PVT LTD.	Active	10.0 L	3	Telangana
TRISAI INFRA PRIVATE LIMITED	Converted to LLP	35.9 L	3	Telangana
AURIS HOLDINGS & INFRASTRUCTURE PRIVATE LIMITED	Strike Off	1.0 L	1	Telangana
VAXENIC INDIA PRIVATE LIMITED	Active	1.0 L	4	Telangana
CLINI-PHARMA LLP	Active	1.0 L	2	Telangana
B E IMMUNO SCIENCES PRIVATE LIMITED	Active	1.0 L	2	Telangana
BIONA HEALTH CARE PRIVATE LIMITED	Strike Off	1.0 L	1	Telangana
VASISHTA TECHNOLOGIES PRIVATE LIMITED	Active	1.0 L	1	Telangana
V.R. TRANSPORT CO PVT LTD	Active	6.0 L	1	Telangana
BE RESEARCH CENTRE	Active	0.0	3	Telangana
HIGH-TECH MEDICALS PRIVATE LIMITED	Strike Off	1.0 L	1	Telangana
B.E. INVESTMENT AND FINANCE PVT LTD	Active	1.0 L	2	Telangana
SUNDER BIOTECH LLP	Active	1.0 L	1	Telangana
BIONA HERBAL RESEARCH CENTRE PRIVATE LIMITED	Active	1.0 L	2	Telangana
DR.REDDY'S INSTITUTE OF LIFE SCIENCES	Active	0.0	1	Telangana
BE IMMUNOLOGY PRIVATE LIMITED	Strike Off	1.0 L	1	Telangana
BE VAXCO PRIVATE LIMITED	Strike Off	1.0 L	1	Andhra Pradesh
BE PHARMACEUTICALS PRIVATE LIMITED	Active	5.0 Cr	2	Telangana

Subsidiary Companies

Name	State / Country	Incorporation Year	Paidup Capital
BIOTECH MEDICALS PRIVATE LIMITED	Telangana	1999	₹ 1.0 Cr
B.E. INVESTMENT AND FINANCE PVT LTD	Telangana	1987	₹ 1.0 L
BE Vaccines PTE Limited, Singapore	Singapore	-	-
VAXENIC INDIA PRIVATE LIMITED	Telangana	2015	₹ 1.0 L
BE Pharmaceuticals AG Zug, Switzerland	Switzerland	-	-
BE PHARMACEUTICALS PRIVATE LIMITED	Telangana	2011	₹ 5.0 Cr
BE PHARMACEUTICALS AG ZUG, SWITZERLAND	Switzerland	-	-

Registered Details

CIN

U01120TG1953PLC001095

PAN

AAACB7873P

Incorporation

1953, 71.3 years

Company Email

mahipalreddy.saddi@biologicale.com

Paid up Capital

₹ 5.0 Cr

Authorised Capital

₹ 5.0 Cr

AGM

Sep 2023

Type

Public

Non-government Company

FAQ - BIOLOGICAL E. LIMITED

What is the incorporation date of BIOLOGICAL E. LIMITED?

The incorporation date of BIOLOGICAL E. LIMITED is 10 December, 1953

What is the authorized share capital of BIOLOGICAL E. LIMITED?

The authorized share capital of BIOLOGICAL E. LIMITED is INR ₹ 5.0 Cr.

What is the paid-up capital of BIOLOGICAL E. LIMITED?

The paid-up capital of BIOLOGICAL E. LIMITED is INR ₹ 5.0 Cr.

What is the registered address of BIOLOGICAL E. LIMITED?

The registered address of BIOLOGICAL E. LIMITED is 18/1 AND 3,AZAMABAD HYDERABAD ANDHRA PRADESH Telangana - 500020

What is the CIN number of BIOLOGICAL E. LIMITED?

The CIN number of BIOLOGICAL E. LIMITED is U01120TG1953PLC001095.

Smart Suggestions

Top Blog Post

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

BIOLOGICAL E. LIMITED

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Industry

Buy Report or Plans

Dashboards

Company dashboard

View subscriptions and buy credits

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Due diligence report

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

Tofler Score

Risk

About Tofler Score

Peers / Similar Companies

Peers

Pfizer Limited

Sanofi Healthcare India Private Limited

Msd Pharmaceuticals Private Limited

Indian Immunologicals Limited

Serum Institute Of India Private Limited

Financial Highlights

Margins

Balance Sheet

Total assets

Profit & Loss

Revenue from operations

Ratios

Ratios

Charges on assets

Charges

People

Company Network